Treatment with gold(I) NHC complexes interferes with this balance and leads to activation of the ASK1-p38-MAPK cascade and in consequence triggers apoptosis in gemcitabine-resistant pancreatic cancer cells. This evidence concerns the gene MAP3K5 and pancreatic neoplasm.